Bluejay Diagnostics, Inc.
BJDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $249 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $200 | $146 |
| Gross Profit | $0 | $0 | $49 | -$146 |
| % Margin | – | – | 19.6% | – |
| R&D Expenses | $3,472 | $5,715 | $4,152 | $1,148 |
| G&A Expenses | $3,690 | $4,313 | $4,763 | $1,792 |
| SG&A Expenses | $3,698 | $4,597 | $5,215 | $2,082 |
| Sales & Mktg Exp. | $8 | $283 | $451 | $290 |
| Other Operating Expenses | $0 | $0 | $0 | -$146 |
| Operating Expenses | $7,170 | $10,311 | $9,367 | $3,084 |
| Operating Income | -$7,170 | -$10,311 | -$9,318 | -$3,230 |
| % Margin | – | – | -3,741.5% | – |
| Other Income/Exp. Net | -$548 | $357 | $21 | -$258 |
| Pre-Tax Income | -$7,718 | -$9,954 | -$9,297 | -$3,488 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7,718 | -$9,954 | -$9,297 | -$3,730 |
| % Margin | – | – | -3,733.1% | – |
| EPS | -42.08 | -72.62 | -73.22 | -29.67 |
| % Growth | 42.1% | 0.8% | -146.8% | – |
| EPS Diluted | -42.08 | -72.62 | -73.22 | -29.67 |
| Weighted Avg Shares Out | 183 | 137 | 126 | 126 |
| Weighted Avg Shares Out Dil | 183 | 137 | 126 | 126 |
| Supplemental Information | – | – | – | – |
| Interest Income | $146 | $165 | $90 | $513 |
| Interest Expense | $823 | $0 | $0 | $367 |
| Depreciation & Amortization | $199 | $781 | $306 | $146 |
| EBITDA | -$6,696 | -$9,173 | -$9,011 | -$3,084 |
| % Margin | – | – | -3,618.5% | – |